tiprankstipranks
Apellis Pharmaceuticals (APLS)
NASDAQ:APLS
US Market
Want to see APLS full AI Analyst Report?

Apellis Pharmaceuticals (APLS) Technical Analysis

1,012 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Apellis Pharmaceuticals’s (APLS) Moving Averages Convergence Divergence (MACD) indicator is 5.43, suggesting Apellis Pharmaceuticals is a Sell.
Apellis Pharmaceuticals’s (APLS) 20-Day exponential moving average is 34.70, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.
Apellis Pharmaceuticals’s (APLS) 50-Day exponential moving average is 28.53, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.

Apellis Pharmaceuticals (APLS) Pivot Points

Apr 21, 2026, 09:18 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
40.72
40.76
40.81
40.86
40.91
40.95
41.01
Fibonacci
40.76
40.80
40.82
40.86
40.89
40.91
40.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Apellis Pharmaceuticals (APLS) Moving Averages

Apr 21, 2026, 09:18 AM
Period
Simple
Exponential
MA5
40.86Buy
40.73Buy
MA10
40.78Buy
39.09Buy
MA20
32.51Buy
34.70Buy
MA50
25.52Buy
28.53Buy
MA100
24.38Buy
25.69Buy
MA200
23.90Buy
23.76Buy
Apellis Pharmaceuticals’s (APLS) 10-Day exponential moving average is 39.09, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.
Apellis Pharmaceuticals’s (APLS) 100-Day exponential moving average is 25.69, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.
Apellis Pharmaceuticals’s (APLS) stock price is $40.9 and Apellis Pharmaceuticals’s (APLS) 50-day simple moving average is 25.52, creating a Buy signal.
Apellis Pharmaceuticals’s (APLS) stock price is $40.9 and Apellis Pharmaceuticals’s (APLS) 100-day simple moving average is 24.38, creating a Buy signal.
Apellis Pharmaceuticals’s (APLS) stock price is $40.9 and Apellis Pharmaceuticals’s (APLS) 200-day simple moving average is 23.90, creating a Buy signal.

Apellis Pharmaceuticals (APLS) Technical Indicators

Apr 21, 2026, 09:18 AM
Name
Value
Implied Action
RSI (14)
87.53
Sell
STOCH (9,6)
91.00
Sell
STOCHRSI (14)
99.84
Sell
MACD (12,26)
5.43
Sell
ADX (14)
62.75
Sell
Williams %R
-0.21
Sell
CCI (14)
52.73
Neutral
ATR (14)
1.07
-
Ultimate Oscillator
75.16
Buy
ROC
141.01
Buy
Apellis Pharmaceuticals’s (APLS) Relative Strength Index (RSI) is 87.53, creating a Sell signal.
Apellis Pharmaceuticals’s (APLS) Trend Strength Indicator (ADX) is 62.75, creating a Sell signal.
Apellis Pharmaceuticals’s (APLS) Commodity Channel Index (CCI) is 52.73, creating a Neutral signal.
Apellis Pharmaceuticals’s (APLS) Price Rate of Change (ROC) is 141.01, creating a Buy signal.

FAQ

Is APLS a Buy, Hold, or Sell?
Based on APLS’s technical indicators, APLS is a Buy.
    What is APLS’s RSI (14)?
    APLS’s RSI (14) is 87.53, which suggests APLS is a Sell.
      What is APLS’s MACD?
      APLS’s MACD is 5.43, which suggests APLS is a Sell.
        What is APLS’s 5-day moving average?
        APLS’s 5-day moving average is 40.86, which suggests APLS is a Buy.
          What is APLS’s 20-day moving average?
          APLS 20-day moving average is 32.51, which suggests APLS is a Buy.
            What is APLS’s 50-day moving average?
            APLS’s 50-day moving average is 25.52, which suggests APLS is a Buy.
              What is APLS’s 200-day moving average?
              APLS’s 200-day moving average is 23.90, which suggests APLS is a Buy.
                What is APLS’s Williams % R (14)?
                APLS’s Williams % R (14) is -0.21, which suggests APLS is a Sell.
                  What is APLS’s CCI (14)?
                  APLS’s CCI (14) is 52.73, which suggests APLS is a Neutral.